TokenPost·
Haemonetics Raises Fiscal 2027 Organic Revenue Growth Outlook to 6% to 9%
Second-quarter organic revenue rose 10% in the period ended Sept. 26, 2026. CSL expects its U.S. center rollout to finish by the end of 2027.
More news
- TokenPostMunster Says AI Budgets Have Room to Grow as Noble Questions Returns
- BeInCrypto3 Altcoins Defy the Crypto Market Crash
- TokenPostVeracyte Shares Fall 56% After Updating 2026 Revenue Outlook
- TokenPostNova Projects Fourth-Quarter Revenue of $305 Million to $315 Million
- Crypto BriefingPolymarket investigates suspicious bets placed hours before NYT/Siena polls
- TokenPostZcash Falls 2.42% in One Hour to $1,293 on Binance Spot